Neuroprotective effect of Ro5-4864 following brain injury

Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c

Liu, X., Kim, C. N., Yang, J., Jemmerson, R., & Wang, X. (1996) · Cell · doi:10.1016/s0092-8674(00)80085-9 · Cited by 5,167 · see citing works

Mitochondrial membrane permeabilization in cell death

Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598 · see citing works

Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP Inhibition

Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513 · see citing works

Identification of DIABLO, a Mammalian Protein that Promotes Apoptosis by Binding to and Antagonizing IAP Proteins

Verhagen, A. M., Ekert, P. G., Pakusch, M., Silke, J., Connolly, L. M., Reid, G. E., Moritz, R. L., Simpson, R. J., & Vaux, D. L. (2000) · Cell · doi:10.1016/s0092-8674(00)00009-x · Cited by 2,372 · see citing works

An APAF-1·Cytochrome c Multimeric Complex Is a Functional Apoptosome That Activates Procaspase-9

Zou, H., Li, Y., Liu, X., & Wang, X. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11549 · Cited by 2,089 · see citing works

THE MITOCHONDRIAL DEATH/LIFE REGULATOR IN APOPTOSIS AND NECROSIS

Kroemer, G., Dallaporta, B., & Resche-Rigon, M. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.619 · Cited by 1,971 · see citing works

Bax directly induces release of cytochrome c from isolated mitochondria

Jürgensmeier, J. M., Xie, Z., Deveraux, Q. L., Ellerby, L., Bredesen, D. E., & Reed, J. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.4997 · Cited by 1,523 · see citing works

Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding

Braestrup, C., & Squires, R. F. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.9.3805 · Cited by 1,264 · see citing works

J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential

Reers, M., Smith, T. W., & Chen, L. B. (1991) · Biochemistry · doi:10.1021/bi00232a015 · Cited by 1,052 · see citing works

Two Distinct Pathways Leading to Nuclear Apoptosis

Susín, S. A., Daugas, É., Ravagnan, L., Samejima, K., Zamzami, N., Loeffler, M. W., Costantini, P., Ferri, K. F., Irinopoulou, T., Prévost, M., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.571 · Cited by 736 · see citing works

Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier

McEnery, M. W., Snowman, A. M., Trifiletti, R. R., & Snyder, S. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3170 · Cited by 708 · see citing works

Cytochrome c Promotes Caspase-9 Activation by Inducing Nucleotide Binding to Apaf-1

Jiang, X., & Wang, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000405200 · Cited by 506 · see citing works

Cytochrome C Maintains Mitochondrial Transmembrane Potential and Atp Generation after Outer Mitochondrial Membrane Permeabilization during the Apoptotic Process

Waterhouse, N. J., Goldstein, J. C., von Ahsen, O., Schüler, M., Newmeyer, D. D., & Green, D. R. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.2.319 · Cited by 452 · see citing works

Programmed cell death via mitochondria: Different modes of dying

Bras, M., Queenan, B., & Susín, S. A. (2005) · Biochemistry (Moscow) · doi:10.1007/s10541-005-0105-4 · Cited by 404 · see citing works

Cyclosporin A Attenuates Acute Mitochondrial Dysfunction Following Traumatic Brain Injury

Sullivan, P. G., Thompson, M. B., & Scheff, S. W. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7197 · Cited by 344 · see citing works

Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]R05-4864 and [3H]PK 11195, by thermodynamic studies

Fur, G. L., Vaucher, N., Perrier, M. L., Flamier, A., Bénavidès, J., Renault, C., Dubroeucq, M. C., Gueremy, C., & Uzan, A. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90794-4 · Cited by 268 · see citing works

An Intrathecal Bolus of Cyclosporin a before Injury Preserves Mitochondrial Integrity and Attenuates Axonal Disruption in Traumatic Brain Injury

Okonkwo, D. O., & Povlishock, J. T. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199904000-00010 · Cited by 265 · see citing works

PK11195, a Ligand of the Mitochondrial Benzodiazepine Receptor, Facilitates the Induction of Apoptosis and Reverses Bcl-2-Mediated Cytoprotection

Hirsch, T., Decaudin, D., Susín, S. A., Marchetti, P., Larochette, N., Resche-Rigon, M., & Kroemer, G. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4084 · Cited by 254 · see citing works

Dominant cell death induction by extramitochondrially targeted apoptosis‐inducing factor

Loeffler, M. W., Daugas, É., Susín, S. A., Zamzami, N., Métivier, D., Nieminen, A., Brothers, G. M., Penninger, J. M., & Kroemer, G. (2001) · The FASEB Journal · doi:10.1096/fj.00-0388com · Cited by 241 · see citing works

Pharmacological manipulation of cell death: clinical applications in sight?

Green, D. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26321 · Cited by 239 · see citing works

Peripheral benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo.

Decaudin, D., Castedo, M., Némati, F., Beurdeley‐Thomas, A., Pinieux, G. D. B. D., Caron, A., Pouillart, P., Wijdenes, J., Rouillard, D., Kroemer, G., et al. (2002) · PubMed · Cited by 155 · see citing works

Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human colorectal cancer cells

Maaser, K., Höpfner, M., Jansen, A., Weisinger, G., Gavish, M., Kozikowski, A. P., Weizman, A., Carayon, P., Riecken, E.-O., Zeitz, M., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2181 · Cited by 120 · see citing works

Peripheral Benzodiazepine Receptor Agonists Exhibit Potent Antiapoptotic Activities

Bono, F., Lamarche, I., Prabonnaud, V., Fur, G. L., & Herbert, J. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1683 · Cited by 118 · see citing works

The peripheral-type benzodiazepine receptor is involved in control of Ca2+-induced permeability transition pore opening in rat brain mitochondria

Azarashvili, T., Grachev, D., Krestinina, O. V., Evtodienko, Y. V., Yurkov, I. S., Papadopoulos, V., & Reiser, G. (2006) · Cell Calcium · doi:10.1016/j.ceca.2006.11.004 · Cited by 112 · see citing works

Ro5-4864, a peripheral benzodiazepine receptor ligand, reduces reactive gliosis and protects hippocampal hilar neurons from kainic acid excitotoxicity

Veiga, S., Azcoitia, I., & Garcia-Segura, L. M. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20430 · Cited by 101 · see citing works

Peripheral-type benzodiazepine receptors in the regulation of proliferation of MCF-7 human breast carcinoma cell line

Carmel, I., Fares, F., Leschiner, S., Scherübl, H., Weisinger, G., & Gavish, M. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00093-3 · Cited by 90 · see citing works

PK11195 potently sensitizes to apoptosis induction independently from the peripheral benzodiazepin receptor

González‐Polo, R. A., Carvalho, G., Braun, T., Decaudin, D., Fabre, C., Larochette, N., Perfettini, J., Djavaheri‐Mergny, M., Youlyouz‐Marfak, I., Codogno, P., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208907 · Cited by 88 · see citing works

Peripheral benzodiazepine receptor ligands: mitochondrial transmembrane potential depolarization and apoptosis induction in rat C6 glioma cells

Chelli, B., Lena, A., Vanacore, R., Pozzo, E. D., Costa, B., Rossi, L., Salvetti, A., Scatena, F., Ceruti, S., Abbracchio, M. P., et al. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.03.008 · Cited by 87 · see citing works

Hyperbaric Oxygen Therapy for Reduction of Secondary Brain Damage in Head Injury: An Animal Model of Brain Contusion

Palzur, E., Vlodavsky, E., Mulla, H., Arieli, R., D, M. F. M., & Soustiel, J. F. (2004) · Journal of Neurotrauma · doi:10.1089/089771504772695931 · Cited by 79 · see citing works

Neuroprotective Anti-Apoptosis Effect of Estrogens in Traumatic Brain Injury

Soustiel, J. F., Palzur, E., Nevo, O., Thaler, I., & Vlodavsky, E. (2005) · Journal of Neurotrauma · doi:10.1089/neu.2005.22.345 · Cited by 78 · see citing works

Bcl-2 resistant mitochondrial toxicity mediated by the isoquinoline carboxamide PK11195 involves de novo generation of reactive oxygen species

Fennell, D. A., Corbo, M., Pallaska, A., & Cotter, F. E. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1788 · Cited by 72 · see citing works

PK 11195 attenuates kainic acid‐induced seizures and alterations in peripheral‐type benzodiazepine receptor (PBR) protein components in the rat brain

Veenman, L. S., Leschiner, S., Spanier, I., Weisinger, G., Weizman, A., & Gavish, M. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2002.00769.x · Cited by 67 · see citing works

Experimental Investigation of Cerebral Contusion: Histopathological and Immunohistochemical Evaluation of Dynamic Cortical Deformation

Shreiber, D. I., Bain, A. C., Ross, D. T., Smith, D. H., Gennarelli, T. A., McIntosh, T. K., & Meaney, D. F. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199902000-00005 · Cited by 63 · see citing works

Peripheral benzodiazepine receptor and its clinical targeting

Decaudin, D. (2004) · Anti-Cancer Drugs · doi:10.1097/00001813-200409000-00001 · Cited by 57 · see citing works

Evidence in favour of a role for peripheral-type benzodiazepine receptor ligands in amplification of neuronal apoptosis

Jord�, E. G., Jim�nez, A. J., Verdaguer, E., Canudas, A. M., Folch, J., Sureda, F. X., Camins, A., & Pall�s, M. (2005) · APOPTOSIS · doi:10.1007/s10495-005-6064-9 · Cited by 56 · see citing works

Mitochondrial Apoptosis and the Peripheral Benzodiazepine Receptor

Castedo, M., Perfettini, J., & Kroemer, G. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021758 · Cited by 49 · see citing works

PK11195, a peripheral benzodiazepine receptor ligand, chemosensitizes acute myeloid leukemia cells to relevant therapeutic agents by more than one mechanism

Banker, D. E., Cooper, J. J., Fennell, D. A., Willman, C. L., Appelbaum, F. R., & Cotter, F. E. (2002) · Leukemia Research · doi:10.1016/s0145-2126(01)00112-6 · Cited by 44 · see citing works

Role of the peripheral benzodiazepine receptor in sensory neuron regeneration

Mills, C. D., Bitler, J. L., & Woolf, C. J. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.07.010 · Cited by 42 · see citing works

Clinical treatments for mitochondrial dysfunctions after brain injury

Merenda, A., & Bullock, R. M. (2006) · Current Opinion in Critical Care · doi:10.1097/01.ccx.0000216573.26686.27 · Cited by 38 · see citing works

Mechanisms of mitochondrial apoptosis induced by peripheral benzodiazepine receptor ligands in human colorectal cancer cells

Maaser, K., Sutter, A. P., & Scherübl, H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.005 · Cited by 33 · see citing works

Peripheral-type benzodiazepine receptors in association with epileptic seizures in EL mice

Nakamoto, Y., Watabe, S., Shiotani, T., & Yoshii, M. (1996) · Brain Research · doi:10.1016/0006-8993(96)00033-9 · Cited by 18 · see citing works

Anticonvulsant actions of nefiracetam on epileptic EL mice and their relation to peripheral-type benzodiazepine receptors

Shiotani, T., Nakamoto, Y., Watabe, S., Yoshii, M., & Nabeshima, T. (2000) · Brain Research · doi:10.1016/s0006-8993(00)01971-5 · Cited by 17 · see citing works

Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders

Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T. C., Fan, J., Akula, N., Groyer, G., Adams, D., & Schumacher, M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3295 · Cited by 930 · see citing works

Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain

Cosenza‐Nashat, M., Zhao, M. ‐., Suh, H. ‐., Morgan, J., Natividad, R., Morgello, S., & Lee, S. C. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.01006.x · Cited by 459 · see citing works

Mitochondria in traumatic brain injury and mitochondrial‐targeted multipotential therapeutic strategies

Cheng, G., Kong, R., Zhang, L., & Zhang, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02025.x · Cited by 345 · see citing works

Macroglia-Microglia Interactions via TSPO Signaling Regulates Microglial Activation in the Mouse Retina

Wang, M., Wang, X., Zhao, L., Ma, W., Rodríguez, I. R., Fariss, R. N., & Wong, W. T. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3153-13.2014 · Cited by 201 · see citing works

Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases

Grammas, P., Martinez, J. M., & Miller, B. B. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001918 · Cited by 203 · see citing works

Translocator protein (18 kDa) TSPO: An emerging therapeutic target in neurotrauma

Papadopoulos, V., & Lecanu, L. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.04.016 · Cited by 178 · see citing works

The role of mitochondrial transition pore, and its modulation, in traumatic brain injury and delayed neurodegeneration after TBI

Mazzeo, A. T., Alessandri, B., Singh, A., & Bullock, M. R. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.05.026 · Cited by 137 · see citing works

Translocator protein (18 kDa)/peripheral benzodiazepine receptor specific ligands induce microglia functions consistent with an activated state

Choi, J., Ifuku, M., Noda, M., & Guilarte, T. R. (2010) · Glia · doi:10.1002/glia.21091 · Cited by 124 · see citing works

‘New/Designer Benzodiazepines’: An Analysis of the Literature and Psychonauts’ Trip Reports

Orsolini, L., Corkery, J., Chiappini, S., Guirguis, A., Vento, A. E., Berardis, D. D., Papanti, D., & Schifano, F. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200110121333 · Cited by 82 · see citing works

Axonal Regeneration and Neuroinflammation: Roles for the Translocator Protein 18 kDa

Girard, C., Liu, S., Adams, D., Lacroix, C., Sinéus, M., Boucher, C., Papadopoulos, V., Rupprecht, R., Schumacher, M., & Groyer, G. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02215.x · Cited by 75 · see citing works

Oxidative Imbalance and Anxiety Disorders

Krolow, R., Arcego, D. M., Noschang, C. G., Weis, S. N., & Dalmaz, C. (2014) · Current Neuropharmacology · doi:10.2174/1570159x11666131120223530 · Cited by 74 · see citing works

Differential Expression of the 18 kDa Translocator Protein (TSPO) by Neoplastic and Inflammatory Cells in Mouse Tumors of Breast Cancer

Zheng, J., Boisgard, R., Siquier-Pernet, K., Decaudin, D., Dollé, F., & Tavitian, B. (2011) · Molecular Pharmaceutics · doi:10.1021/mp100433c · Cited by 54 · see citing works

The 18-kDa Translocator Protein PET Tracers as a Diagnostic Marker for Neuroinflammation: Development and Current Standing

Singh, P., Adhikari, A., Singh, D., Gond, C., & Tiwari, A. K. (2022) · ACS Omega · doi:10.1021/acsomega.2c00588 · Cited by 47 · see citing works

Translocator protein (TSPO) ligands for the diagnosis or treatment of neurodegenerative diseases: a patent review (2010–2015; part 1)

Kim, T., & Pae, A. N. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1230606 · Cited by 43 · see citing works

Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection

Pozzo, E. D., Giacomelli, C., Barresi, E., Costa, B., Taliani, S., Settimo, F. D., & Martini, C. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150028 · Cited by 41 · see citing works

GABA(A) receptor-targeted drug development -New perspectives in perioperative anesthesia

Antkowiak, B., & Rammes, G. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1599356 · Cited by 39 · see citing works

Therapeutic actions of translocator protein (18 kDa) ligands in experimental models of psychiatric disorders and neurodegenerative diseases.

Arbo, B. D., Benetti, F., García-Segura, L., & Ribeiro, M. (2015) · Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.07.007 · Cited by 35 · see citing works

Etifoxine Restores Mitochondrial Oxidative Phosphorylation and Improves Cognitive Recovery Following Traumatic Brain Injury

Palzur, E., Edelman, D., Sakas, R., & Soustiel, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312881 · Cited by 32 · see citing works

Mitochondrial Damage: A Target for New Therapeutic Horizons

Soustiel, J. F., & Larisch, S. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2009.11.001 · Cited by 29 · see citing works

Progesterone: Synthesis, Metabolism, Mechanism of Action, and Effects in the Nervous System

Schumacher, M., Zhu, X., & Guennoun, R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00054-7 · Cited by 28 · see citing works

Reduction of Traumatic Brain Damage by Tspo Ligand Etifoxine

Shehadeh, M., Palzur, E., Apel, L., & Soustiel, J. F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112639 · Cited by 26 · see citing works

Investigation of the mechanisms of neuroprotection mediated by Ro5-4864 in brain injury

Palzur, E., Sharon, A., Shehadeh, M., & Soustiel, J. F. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.05.014 · Cited by 26 · see citing works

The translocator protein as a drug target in Alzheimer’s disease

Chua, S. W., Kassiou, M., & Ittner, L. M. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.896201 · Cited by 20 · see citing works

Etifoxine promotes glial-derived neurotrophic factor-induced neurite outgrowth in PC12 cells

Zhou, X., HE, X., He, B., Zhu, Z., Zheng, C., Xu, J., Jiang, L., Gu, L., Zhu, J., Zhu, Q., et al. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1474 · Cited by 20 · see citing works

4′-Chlorodiazepam Protects Mitochondria in T98G Astrocyte Cell Line from Glucose Deprivation

Báez-Jurado, E., Guio-Vega, G. P., Echeverrı́a, V., Sandoval-Rueda, D. A., & Barreto, G. E. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9733-x · Cited by 19 · see citing works

The Ligands of Translocator Protein: Design and Biological Properties

Мокров, Г. В., Деева, О. А., & Гудашева, Т. А. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200903122025 · Cited by 17 · see citing works

TSPO regulation in reactive gliotic diseases

McNeela, A. M., Bernick, C. B., Hines, R. M., & Hines, D. J. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24212 · Cited by 18 · see citing works

A Protective Role of Translocator Protein in Alzheimer’s Disease Brain

Jung, M. E. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200217105950 · Cited by 15 · see citing works

Improvement of Cerebral Metabolism Mediated by Ro5-4864 is Associated with Relief of Intracranial Pressure and Mitochondrial Protective Effect in Experimental Brain Injury

Soustiel, J. F., Vlodavsky, E., Milman, F., Gavish, M., & Zaaroor, M. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0463-0 · Cited by 15 · see citing works

Chronic benzodiazepine suppresses translocator protein and elevates amyloid β in mice

Tan, S., Metzger, D. B., & Jung, M. E. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.07.005 · Cited by 13 · see citing works

Translocator Protein Regulate Polarization Phenotype Transformation of Microglia after Cerebral Ischemia–reperfusion Injury

Yusuying, S., Yusuyin, S., & Cheng, X. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.09.024 · Cited by 12 · see citing works

Design and synthesis of novel 1,4-benzodiazepine surrogates as potential CCKA and CCKB antagonists via palladium-catalyzed three-component cascade reactions

Döndaş, H. A., Belveren, S., Poyraz, S., Grigg, R., Kilner, C. A., Ferrándiz-Saperas, M., Selva, E., & Sansano, J. M. (2017) · Tetrahedron · doi:10.1016/j.tet.2017.11.017 · Cited by 13 · see citing works

Safety, Tolerability, and Pharmacokinetic Profile of the Novel Translocator Protein 18 kDa Antagonist ONO-2952 in Healthy Volunteers

Suto, F., Wood, A., Kobayashi, M., Komaba, J., Duffy, K. J., & Bruce, M. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.07.010 · Cited by 11 · see citing works

Discovery of thienopyrrolotriazine derivatives to protect mitochondrial function against Aβ-induced neurotoxicity

Kim, T.-H., Son, W. S., Morshed, M. N., Londhe, A. M., Jung, S. Y., Park, J., Park, W., Lim, S. M., Park, K. D., Cho, S. J., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.09.033 · Cited by 11 · see citing works

Activation of translocator protein alleviates mechanical allodynia and bladder dysfunction in cyclophosphamide‐induced cystitis through repression of BDNF‐mediated neuroinflammation

Huang, Y. L., Su, M., Zhang, C., Zhan, H., Yang, F., Gao, Z., Zhou, X., & Liu, B. (2022) · European Journal of Pain · doi:10.1002/ejp.1942 · Cited by 10 · see citing works

Comparative Assessment of TSPO Modulators on Electroencephalogram Activity and Exploratory Behavior

Hines, R. M., Aquino, E. A., Khumnark, M., Dávila, M. P., & Hines, D. J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.750554 · Cited by 6 · see citing works

[125 I]IodoDPA-713 Binding to 18 kDa Translocator Protein (TSPO) in a Mouse Model of Intracerebral Hemorrhage: Implications for Neuroimaging

Bonsack, F., Foss, C. A., Arbab, A. S., Alleyne, C. H., Pomper, M. G., & Sukumari‐Ramesh, S. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00066 · Cited by 5 · see citing works

The 18 kDa Translocator Protein as a Potential Participant in Atherosclerosis

Dimitrova‐Shumkovska, J., Veenman, L., & Gavish, M. (2012) · InTech eBooks · doi:10.5772/25781 · Cited by 3 · see citing works

Novel benzodiazepines

Wolfe, C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818788-3.00013-9 · Cited by 3 · see citing works

Simvastatin-induced neuroprotective effect after brain injury is mediated by mitochondrial protection through modulation of the 18 kDa translocator protein

Sakas, R., Fishboom, T., Ben-Menashe, A., Awad-Igbaria, Y., Nasra, R., Samson, A. O., Palzur, E., & Soustiel, J. F. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00803 · Cited by 1 · see citing works

Head Injury: Metabolic, Nutritional, and Energy Considerations

Charrueau, C., Morio, B., & Moinard, C. (2011) · Springer eBooks · doi:10.1007/978-0-387-92271-3_103 · Cited by 1 · see citing works

Peripheral benzodiazepine receptor TSPO needs to be reconsidered before using as a drug target for a pigmentary disorder

Yue, Y., Wang, Y., Liao, Z., Hu, F., Liu, Q., Dong, J., Zhong, M., Chen, M., Pan, Y., Zhong, H., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202101746rr · Cited by 1 · see citing works

The translocator protein as a drug target in Alzheimer's

Chua, S. W., Kassiou, M., & Ittner, L. M. (2014)

Attenuation of Reactive Astrogliosis Accompanies Neurological Recovery Induced by Novel Poly-Target 2,3-Benzodiazepines After Experimental Traumatic Brain InjuryPreprint

Ziablitsev, S. V., Aleksandrenko, N. O., Yevstifeiev, D. I., Babenko, M., & Likhodiievskyi, V. V. (2026) · Research Square · doi:10.21203/rs.3.rs-10044242/v1

BindingDB Entry 50001420: Discovery of thienopyrrolotriazine derivatives to protect mitochondrial function against Aβ-induced neurotoxicity.

BindingDB (2020) · UC San Diego · doi:10.7270/q2zg6vrm

Investigation of the mechanisms of neuroprotection mediated by Ro5-4864 in brain injury

Palzur, E., Sharon, A., Shehadeh, M., & Soustiel, J. F. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.05.014 · Cited by 26 · see citing works

Translocator protein (18 kDa) TSPO: An emerging therapeutic target in neurotrauma

Papadopoulos, V., & Lecanu, L. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.04.016 · Cited by 178 · see citing works

The mitochondria permeability transition pore complex in the brain with interacting proteins – promising targets for protection in neurodegenerative diseases

Azarashvili, T., Stricker, R., & Reiser, G. (2010) · Biological Chemistry · doi:10.1515/bc.2010.070 · Cited by 57 · see citing works

A Protective Role of Translocator Protein in Alzheimer’s Disease Brain

Jung, M. E. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200217105950 · Cited by 15 · see citing works

Direct inhibition of the mitochondrial permeability transition pore: A possible mechanism for better neuroprotective effects of allopregnanolone over progesterone

Sayeed, I., Parvez, S., Wali, B., Siemen, D., & Stein, D. G. (2009) · Brain Research · doi:10.1016/j.brainres.2009.01.045 · Cited by 116 · see citing works